Preclinical Alzheimer's disease describes the stage where abnormal accumulation of amyloid beta (Aβ) plaque deposition and neurofibrillary tau tangles in the brain may already be in progress, with no significant clinical symptoms.1 This evidence concerns the gene MAPT and Alzheimer disease.